These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 28381803)
1. Artesunate Suppresses the Growth of Prostatic Cancer Cells through Inhibiting Androgen Receptor. Wang Z; Wang C; Wu Z; Xue J; Shen B; Zuo W; Wang Z; Wang SL Biol Pharm Bull; 2017; 40(4):479-485. PubMed ID: 28381803 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of the effects of androgenic Chinese herbal medicines on androgen receptors and tumor growth in experimental prostate cancer models. Zhang ZB; Ip SP; Cho WC; Hu Z; Huang YF; Luo DD; Xian YF; Lin ZX J Ethnopharmacol; 2020 Oct; 260():113058. PubMed ID: 32525068 [TBL] [Abstract][Full Text] [Related]
3. Neoisoliquiritin exerts tumor suppressive effects on prostate cancer by repressing androgen receptor activity. Chen C; Shao R; Li B; Zhai Y; Wang T; Li X; Miao L; Huang J; Liu R; Liu E; Zhu Y; Gao X; Zhang H; Wang Y Phytomedicine; 2021 May; 85():153514. PubMed ID: 33676083 [TBL] [Abstract][Full Text] [Related]
4. Identification of an anabolic selective androgen receptor modulator that actively induces death of androgen-independent prostate cancer cells. Schmidt A; Meissner RS; Gentile MA; Chisamore MJ; Opas EE; Scafonas A; Cusick TE; Gambone C; Pennypacker B; Hodor P; Perkins JJ; Bai C; Ferraro D; Bettoun DJ; Wilkinson HA; Alves SE; Flores O; Ray WJ J Steroid Biochem Mol Biol; 2014 Sep; 143():29-39. PubMed ID: 24565564 [TBL] [Abstract][Full Text] [Related]
5. A new flavonoid derivative exerts antitumor effects against androgen-sensitive to cabazitaxel-resistant prostate cancer cells. Naito R; Kano H; Shimada T; Makino T; Kadomoto S; Iwamoto H; Yaegashi H; Izumi K; Kadono Y; Nakata H; Saito Y; Goto M; Nakagawa-Goto K; Mizokami A Prostate; 2021 Apr; 81(5):295-306. PubMed ID: 33493355 [TBL] [Abstract][Full Text] [Related]
7. Regulation of androgen receptor expression by Z-isochaihulactone mediated by the JNK signaling pathway and might be related to cytotoxicity in prostate cancer. Liu PY; Lin SZ; Sheu JJ; Lin CT; Lin PC; Chou YW; Huang MH; Chiou TW; Harn HJ Prostate; 2013 Apr; 73(5):531-41. PubMed ID: 23038474 [TBL] [Abstract][Full Text] [Related]
8. [Androgen receptor silencing by shRNA inhibits human prostate cancer xenograft growth in nude mice]. Wang T; Xu QQ; Huang XB; Wang XF Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Aug; 45(4):527-31. PubMed ID: 23939155 [TBL] [Abstract][Full Text] [Related]
9. Zyflamend inhibits the expression and function of androgen receptor and acts synergistically with bicalutimide to inhibit prostate cancer cell growth. Yan J; Xie B; Capodice JL; Katz AE Prostate; 2012 Feb; 72(3):244-52. PubMed ID: 21656835 [TBL] [Abstract][Full Text] [Related]
10. Androgen receptor and E2F-1 targeted thymoquinone therapy for hormone-refractory prostate cancer. Kaseb AO; Chinnakannu K; Chen D; Sivanandam A; Tejwani S; Menon M; Dou QP; Reddy GP Cancer Res; 2007 Aug; 67(16):7782-8. PubMed ID: 17699783 [TBL] [Abstract][Full Text] [Related]
11. A molecule inducing androgen receptor degradation and selectively targeting prostate cancer cells. Auvin S; Öztürk H; Abaci YT; Mautino G; Meyer-Losic F; Jollivet F; Bashir T; de Thé H; Sahin U Life Sci Alliance; 2019 Aug; 2(4):. PubMed ID: 31431473 [TBL] [Abstract][Full Text] [Related]
12. Antiandrogenic effects of novel androgen synthesis inhibitors on hormone-dependent prostate cancer. Long BJ; Grigoryev DN; Nnane IP; Liu Y; Ling YZ; Brodie AM Cancer Res; 2000 Dec; 60(23):6630-40. PubMed ID: 11118046 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of human prostate cancer xenograft growth by 125I labeled triple-helix forming oligonucleotide directed against androgen receptor. Zhang Y; Ma Y; Lu HP; Gao JH; Liang CS; Liu CZ; Zou JT; Wang HQ Chin Med J (Engl); 2008 Nov; 121(22):2284-9. PubMed ID: 19080333 [TBL] [Abstract][Full Text] [Related]
14. Metabolically stable diphenylamine derivatives suppress androgen receptor and BET protein in prostate cancer. Yu J; Zhou P; Du W; Xu R; Yan G; Deng Y; Li X; Chen Y Biochem Pharmacol; 2020 Jul; 177():113946. PubMed ID: 32247852 [TBL] [Abstract][Full Text] [Related]
15. The andean anticancer herbal product BIRM causes destabilization of androgen receptor and induces caspase-8 mediated-apoptosis in prostate cancer. Shamaladevi N; Araki S; Lyn DA; Ayyathurai R; Gao J; Lokeshwar VB; Navarrete H; Lokeshwar BL Oncotarget; 2016 Dec; 7(51):84201-84213. PubMed ID: 27705939 [TBL] [Abstract][Full Text] [Related]
16. Revealing the mechanism of ethyl acetate extracts of Semen Impatientis against prostate cancer based on network pharmacology and transcriptomics. Hu B; Wang C; Wu Y; Han C; Liu J; Chen R; Wang T J Ethnopharmacol; 2024 Aug; 330():118228. PubMed ID: 38643863 [TBL] [Abstract][Full Text] [Related]
17. Herbal extract of Wedelia chinensis attenuates androgen receptor activity and orthotopic growth of prostate cancer in nude mice. Tsai CH; Lin FM; Yang YC; Lee MT; Cha TL; Wu GJ; Hsieh SC; Hsiao PW Clin Cancer Res; 2009 Sep; 15(17):5435-44. PubMed ID: 19690196 [TBL] [Abstract][Full Text] [Related]
18. Differential effects of PXD101 (belinostat) on androgen-dependent and androgen-independent prostate cancer models. Gravina GL; Marampon F; Giusti I; Carosa E; Di Sante S; Ricevuto E; Dolo V; Tombolini V; Jannini EA; Festuccia C Int J Oncol; 2012 Mar; 40(3):711-20. PubMed ID: 22134754 [TBL] [Abstract][Full Text] [Related]
19. White button mushroom (Agaricus bisporus) disrupts androgen receptor signaling in human prostate cancer cells and patient-derived xenograft. Wang X; Ha D; Mori H; Chen S J Nutr Biochem; 2021 Mar; 89():108580. PubMed ID: 33388344 [TBL] [Abstract][Full Text] [Related]
20. Regulation and methylation of tumor suppressor miR-124 by androgen receptor in prostate cancer cells. Chu M; Chang Y; Guo Y; Wang N; Cui J; Gao WQ PLoS One; 2015; 10(4):e0116197. PubMed ID: 25860954 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]